BOLD: Boundless Bio Inc Amount of Cash per Share

Corporate emblem and logo of boundlessbio.com (BOLD)

Boundless Bio, Inc. (BOLD) expert management is implementing advanced methods to combat resistant cancer. The strategy is based on the expansion of the Spyglass platform to capture the oncology drug market. However, the R&D stage and lack of sales are increasing unit costs. The cash per share trend reflects the burn rate of reserves, and 2.64 expresses the current value of the metric, determining the company's financial stability.

Boundless Bio Inc (BOLD) Cash Funds per Share: for the period 03/29/2024 - 11/20/2026

Analytical breakdowns for Boundless Bio Inc. (BOLD)

- market price and analyst price targets:
- market capitalization information:
- cash position and cash flow details:
Summary company analysis:Boundless Bio Inc
Signature product of Boundless Bio

For Boundless Bio, Inc. (BOLD), the cash per share reflects the size of the liquid reserve attributable to a single security. This metric is calculated by dividing total cash assets by the total number of shares outstanding. This indicator determines the fundamental margin of safety and the company's ability to fund its operating activities. For Boundless Bio, Inc. (BOLD), this resource is critical while awaiting the first clinical trial results. Current post-IPO liquidity is already priced into the market value.

Analysis of competing companies

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|Cash Funds per Single Share RCKT|Cash per Single Share FDMT|Cash Funds per Single Share LXEO (Lexeo Therapeutics)|Cash per Share KRRO|Editas Medicine, Inc. - Cash Funds per Single Share|Cash Funds per Share Silence Therapeutics Inc. SLN|Cash per Share ProQR Therapeutics N.V. PRQR|CDXS: Cash per Single Share|Cash Funds Volume per Share Sangamo (SGMO)|NAUT (Nautilus Bio) - Cash per Single Share|MGX - Cash Funds Calculated per Share|DTIL (Precision BioSciences Inc.) - Cash per Share|generationbio.com (GBIO) - Cash Funds Calculated per Share|Cash per Single Share XCUR (exicuretx.com)|Imunon Inc - Cash Funds per Single Share|Cash per Share PHIO (Phio Pharmaceuticals Corp)|Amount of Cash per Share MBIO|RNAZ - Cash Funds per Share|Amount of Cash per Share BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Cash Funds per Share|Bluebird Bio - Amount of Cash per Share|IPA (ImmunoPrecise Antibodies Ltd) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology